US Director of Health Economics Outcomes Research (Population Health)

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. What You'll Do The US Director, Health Economics & Outcomes Research (HEOR) will serve as the strategic lead for US population health value demonstration for assigned BridgeBio therapies. This role is responsible for shaping and executing HEOR strategies that support access and utilization decisions across the product lifecycle. We have 2 field based roles based in the Central and East regions. The Director will partner cross-functionally with Market Access, Medical Affairs, Commercial, Clinical Development and Statistics teams to ensure the generation and communication of robust, decision-relevant evidence for US payers, health systems, and other population health decision makers. Responsibilities : Lead the development and strategic deployment of HEOR evidence, economic models and resources to support US payer and health system engagement, including training and partnership with Market Access, Field Medical, and Sales Leadership Gather IDN and payer insights around evidence requirements to ensure differentiation of BridgeBio therapies Provide strategic input into HEOR real world evidence, study design and execution to ensure relevance for US population health decision-making Lead development of AMCP Dossiers, Budget Impact Models and other economic tools to support the commercialization of BridgeBio therapies Lead external collaborations with KOLs and Centers of Excellence to drive evidence generation, publications, and credibility with payer and health system leadership Conduct HEOR advisory boards and market research as needed to understand evolving evidence requirements and gaps for payers and IDNs in assigned therapeutic areas Collaborate with Head of HEOR and Market Access colleagues in ICER assessments and responses related to assigned Where You'll Work We have (2) field based roles located in the Central and East which requires domestic travel as required, approximately 20-30% Who You Are A Master's Degree in a relevant discipline (e.g., health economics, health services research, medicine, pharmacy, public health, psychometrics, epidemiology, and decision sciences) required 8+ years of relevant experience with an emphasis on the pharmaceutical/medical device industry and/or managed care experience; 6+ years of experience in health economics and outcomes research Comprehensive understanding of the US healthcare landscape, factors driving decision making and US payer policy Demonstrated ability to lead without authority and influence across teams and functions Outstanding executive presence and ability to translate complex HEOR evidence into clear, compelling value narratives for payer and executive audiences Well organized with the ability to multitask, prioritize, and manage shifting responsibilities in a small, fast-moving, and entrepreneurial environment #LI-LN1 At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity,